MRI Imaging Study for Brain Lymphoma Biopsies

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.

Recruiting Observational Study
Cerebral Lymphoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
15 (estimated)
Sponsor
IRCCS San Raffaele · Other
Who this trial is looking for

This trial is looking for adults who are having a specific type of brain biopsy for newly diagnosed brain lymphoma. Participants will have MRI scans to help understand the relationship between images and tissue samples.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult
  • I am undergoing a stereotactic biopsy for newly diagnosed PCNSL

You may not be able to join if

  • I have severe liver problems
  • I have severe kidney problems
  • I have severe heart failure
  • I have had a heart attack or stroke in the past 90 days
  • I have a serious reaction to contrast agents
  • I am pregnant

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. The aim of this study is to evaluate the MRI imaging characteristics of the peritumoral area (PTA) and to correlate this information to pathological findings.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients, undergoing stereotactic biopsy for newly diagnosed PSNCLs Exclusion Criteria: * Severe hepatic dysfunction * Severe renal dysfunction * Severe heart failure * myocardial infarction and stroke within 90 days * Hyperreactivity against contrast agents * Pregnanc…
Contacts

Laura Sincinelli

+390226435568

sincinelli.laura@hsr.it

CONTACT